Axogen (AXGN) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.64% |
| Dec 31, 2025 | 13.01% |
| Sep 30, 2025 | 12.44% |
| Jun 30, 2025 | 20.70% |
| Mar 31, 2025 | 14.89% |
| Dec 31, 2024 | 11.90% |
| Sep 30, 2024 | 11.24% |
| Jun 30, 2024 | 12.40% |
| Mar 31, 2024 | 12.19% |
| Dec 31, 2023 | 12.87% |
| Sep 30, 2023 | 12.74% |
| Jun 30, 2023 | 13.14% |
| Mar 31, 2023 | 16.26% |
| Dec 31, 2022 | 16.34% |
| Sep 30, 2022 | 18.16% |
| Jun 30, 2022 | 17.83% |
| Mar 31, 2022 | 20.43% |
| Dec 31, 2021 | 22.55% |
| Sep 30, 2021 | 22.73% |
| Jun 30, 2021 | 26.46% |
| Mar 31, 2021 | 30.78% |
| Dec 31, 2020 | 33.00% |
| Sep 30, 2020 | 32.60% |
| Jun 30, 2020 | 28.08% |
| Mar 31, 2020 | 37.42% |
| Dec 31, 2019 | 42.50% |
| Sep 30, 2019 | 43.64% |
| Jun 30, 2019 | 44.66% |
| Mar 31, 2019 | 49.31% |
| Dec 31, 2018 | 51.00% |
| Sep 30, 2018 | 50.27% |
| Jun 30, 2018 | 48.38% |
| Mar 31, 2018 | 51.78% |
| Dec 31, 2017 | 52.69% |
| Sep 30, 2017 | 51.95% |
| Jun 30, 2017 | 49.77% |
| Mar 31, 2017 | 49.24% |
| Dec 31, 2016 | 52.98% |
| Sep 30, 2016 | 57.92% |
| Jun 30, 2016 | 53.32% |
| Mar 31, 2016 | 48.55% |
| Dec 31, 2015 | 57.39% |
| Sep 30, 2015 | 59.06% |
| Jun 30, 2015 | 356.02% |